Raymond James Maintains Outperform on ICU Medical, Raises Price Target to $190
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has maintained an 'Outperform' rating on ICU Medical (NASDAQ:ICUI) and raised the price target from $158 to $190.
September 12, 2024 | 12:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James has reaffirmed its 'Outperform' rating for ICU Medical and increased the price target to $190, indicating confidence in the company's future performance.
The increase in price target from $158 to $190 by Raymond James suggests a positive outlook for ICU Medical, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100